Criteo
CRTO
15.02
+0.12
+0.81%
Criteo
US · CRTO
#3480 by market cap
15.02
+0.12
+0.81%
Live - 5344 symbols - heartbeat 28s ago
· 2026-10-08 10:05
Pre-market
14.86
-0.25%
After-hours
14.90
0.00%
- Market cap
- 735.94M
- P/E (TTM)i
- 7.66
- P/Bi
- 0.65
- EPSi
- 2.64
- Div yieldi
- 0.00%
- 52W posi
- 7%
Reader sentiment
Are you bullish or bearish on CRTO?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 124 in the most recent period (2026/Q3).
- Total institutional ownership fell 81.8 percentage points.
Institutional ownership
- Held by institutions
- 4.16% -81.81pp
- Institutions
- 13 -124
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund4.16%
Individual/Insider2.30%
Other93.54%
Top holders as of 2026-07-31
Neuberger Berman Investment Advisers LLC
1.88% · 923.15K sh
VELA Investment Management LLC
0.96% · 470.15K sh
Sarah J. Glickman
0.87% · 424.61K sh
Michael Komasinski
0.70% · 343.89K sh
ClearBridge Investments, LLC
0.50% · 243.90K sh
Connor McGogney
0.38% · 185.35K sh
Ryan Damon
0.33% · 163.77K sh
Charles Schwab Investment Management
0.27% · 130.66K sh
SEI Investments Company
0.13% · 62.16K sh
FMR
0.06% · 30.86K sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 17 buys · 32 sells
| Name | Role | Stake |
|---|---|---|
| Sarah J. Glickman | Chief Financial Officer | 0.87% |
| Michael Komasinski | Chief Executive Officer | 0.70% |
| Connor McGogney | Chief Business Development Officer | 0.38% |
| Ryan Damon | Chief Legal & Corporate Affairs Officer | 0.33% |
| Stefanie Jay | Independent Director | 0.02% |
| Edmond Mesrobian | Independent Director | -- |
| Hubert de Pesquidoux | Independent Director | -- |
| Nathalie Balla | Independent Director | -- |
| Ernst Teunissen | Independent Director | -- |
| Brian Gleason | Chief Revenue Officer | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-31 | Ryan Damon | Chief Legal & Corporate Affairs Officer | Open Market Disposition | -1,079 | $17.50 |
| 2026-08-31 | Sarah J. Glickman | Chief Financial Officer | Intent to Sell (Form 144) | -982 | $17.50 |
| 2026-08-31 | Connor McGogney | Chief Business Development Officer | Open Market Disposition | -276 | $17.50 |
| 2026-08-30 | Stefanie Jay | Independent Director | Other Acquisition | +6,200 | $17.72 |
| 2026-08-27 | Michael Komasinski | Chief Executive Officer | Open Market Disposition | -1,656 | $17.28 |
| 2026-08-27 | Ryan Damon | Chief Legal & Corporate Affairs Officer | Open Market Disposition | -789 | $17.28 |
| 2026-08-27 | Sarah J. Glickman | Chief Financial Officer | Intent to Sell (Form 144) | -803 | $17.28 |
| 2026-08-27 | Connor McGogney | Chief Business Development Officer | Open Market Disposition | -258 | $17.28 |
| 2026-08-23 | Ryan Damon | Chief Legal & Corporate Affairs Officer | Open Market Disposition | -2,132 | $17.37 |
| 2026-08-23 | Connor McGogney | Chief Business Development Officer | Open Market Disposition | -671 | $17.37 |
| 2026-08-09 | Connor McGogney | Chief Business Development Officer | Other Acquisition | +23,090 | -- |
| 2026-08-09 | Connor McGogney | Chief Business Development Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-08-05 | Michael Komasinski | Chief Executive Officer | Open Market Disposition | -15,559 | $17.23 |
| 2026-08-05 | Ryan Damon | Chief Legal & Corporate Affairs Officer | Open Market Disposition | -6,178 | $17.23 |
| 2026-08-05 | Sarah J. Glickman | Chief Financial Officer | Open Market Disposition | -6,285 | $17.23 |
| 2026-07-28 | Edmond Mesrobian | Independent Director | Sale to Issuer | -32,187 | -- |
| 2026-07-28 | Edmond Mesrobian | Independent Director | Other Acquisition | +32,187 | -- |
| 2026-07-28 | Michael Komasinski | Chief Executive Officer | Sale to Issuer | -361,106 | -- |
| 2026-07-28 | Michael Komasinski | Chief Executive Officer | Other Acquisition | +361,106 | -- |
| 2026-07-28 | Nathalie Balla | Independent Director | Sale to Issuer | -33,846 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 10:05:51 · For reference only, not investment advice and not tailored to your situation.